Infections were reported, as expected in RA, with no apparent patterns related to etiology, type, or dose with ABT-122 vs PBO, and no pt discontinued the study owing to infection. There were no clinically significant laboratory, vital sign, or ECG abnormalities. CXCL9 and CXCL10 decreased ...